Adial Pharmaceuticals, Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2017 | $-494.9K | $-494.9K | — | $205.4K |
| FY2018 | $-2.5M | $-2.5M | — | $5.4M |
| FY2019 | $-6.3M | $-6.3M | — | $1.6M |
| FY2020 | $-7.6M | $-7.6M | — | $2.0M |
| FY2021 | $-11.9M | $-12.0M | $64.6K | $4.2M |
| FY2022 | $-11.2M | $-11.2M | — | $3.4M |
| FY2023 | $-6.8M | $-6.8M | — | $1.7M |
| FY2024 | $-6.9M | $-6.9M | — | $796.8K |
| FY2025 | $-6.5M | $-6.5M | — | $676.2K |